SNHG7 and breast carcinoma: Furthermore, the knockdown of lncRNA SNHG7 reduces drug resistance and inhibits stemness in breast cancer cells via miR‐34a, which indicates that lncRNA SNHG7 may be a potential therapeutic target to overcome chemoresistance in breast cancer patients.